FERMT2 _LIHC.png
Expression analysis of TCGA samples
Basic Information
VIS ID
TVIS10010629
Fusion event
HBV-FERMT2 integration
Validated
No
Detection method
NGS
Data source
Curated
Sample type
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Reported year
2018
PubMed ID
Virus Sequence
Virus name
HBV
Reference genome
Region type
X protein|precore/core protein|
Start
1822
Orient
+
Integrated sequence
GTTTAAAGACTGGGAGGAGTTGGGGGAGGAGATTAGGTTAAAGGTCTTTGTACTAGGAGGCTGTAGGCATAAATTGGTCTGCGCACCAGCACCATGCAAC| |TTTTTCACCTCTGCCTAATCATCTCTTGTTCATGTCCTACTGTTCAAGCCTCCAAGCTGTGCCTTGGGTGGCTTTGGGGCATGGACATCGACCCTTATAA
Host Sequence
Chromosome
chr14
Cytoband
q22.1
Reference genome
End
53399656/52932938 (Hg38)
Orient
-
Location type
Intronic
Target gene
Nearest miRNA
hsa-mir-208a/Upstream/2632992; hsa-mir-1185-1/Downstream/1015489;
Upstream sequence
ATTCTCAACAGTGCAATCTACAACACTATCATCCAGGACCTAACTGAAGTTTTTATAATATGAGTTTCCACAACCATGAAAAACAGGAAAAGAATACCCA
Downstream sequence
ACATATACTTTTGAACTCTGCTGAATCTTATTCTCTCATATAGCGTTATTATTAATCAACAAAATGTAAAACAACAAAGAAATGAACAAAAAAAAACACT
Reference
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.
Curate